biotech
biotech Articles
Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the...
Published:
Revolution Medicines entered the market with a bang on Thursday. Although the company only priced shares are $17 apiece, the stock actually entered the market closer to $28.
Published:
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the timing for its IPO, but it managed to get back into favor with investors....
Published:
Amarin is a development-stage biotechnology company with one FDA-approved treatment, a cardiovascular disease drug with no real competition. The company looks well-poised to boost sales in 2020 and...
Published:
Collegium Pharma shares popped on Friday after the firm announced that it will acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics.
Published:
Aquestive Therapeutics shares jumped on Thursday after the firm announced that it had a constructive face-to-face meeting with the FDA concerning its “first of its kind” treatment of anaphylaxis.
Published:
Vivus shares jumped on Wednesday after the company announced a crucial FDA for its supplemental New Drug Application for an improved formulation of Pancreaze.
Published:
Insmed is one of the few biotechs not tied to the coronavirus that is making a big move to start out the week. Essentially, the firm reported midstage study results for patients with non-cystic...
Published:
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
Published:
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
Published:
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Published:
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
Published:
A positive research call indicates that Madrigal Pharmaceuticals shares could deliver more than 100% upside to investors over the coming year or so.
Published:
OpGen shares jumped on Thursday after the company announced that it will be joining the fight against the latest coronavirus outbreak.
Published: